Roshan PK: Breaking Down Pulmonary Embolism Treatment By Risk Level
Roshan PK, Assistant Professor, Emergency Physician at Government Medical College, posted on LinkedIn:
”Breaking Down Pulmonary Embolism (PE) Treatment by Risk Level
From the 2022 NEJM Review on Pulmonary Embolism – a comprehensive guide by Kahn and de Wit:
Low-Risk PE (Stable, no RV strain or elevated biomarkers):
• Start with oral anticoagulants like apixaban (10mg 2x/day for 7 days, then 5mg 2x/day) or rivaroxaban.
• Outpatient treatment often safe if no other concerns.
• No thrombolysis or embolectomy needed.
• Duration: At least 3 months; longer if high recurrence risk.
Intermediate-Risk PE (Stable but with RV dysfunction or high biomarkers):
• Immediate low-molecular-weight heparin (LMWH) for anticoagulation.
• Hospital monitoring essential – watch for worsening.
• Thrombolysis only if deteriorating (systemic preferred; catheter-directed as alternative).
• Embolectomy if high bleeding risk or near-shock.
• Same duration as low-risk.
High-Risk PE (Unstable with hypotension/shock):
• IV unfractionated heparin + reperfusion therapy.
• Systemic thrombolysis first if no high bleeding risk.
• Surgical or catheter-directed embolectomy if thrombolysis contraindicated or fails.
• Urgent action to stabilize
Remember, risk stratification uses hemodynamics, imaging, and biomarkers. Always seek professional medical advice – this is for info only.”
Stay updated with Hemostasis Today.
-
Feb 16, 2026, 13:33Anne Hege Aamodt Congratulates Gisle Berg Helland on PhD Defense About Stroke Outcome MRI and ML Prediction
-
Feb 16, 2026, 13:25Rucha Patil: Delighted to Contribute to The Round Table on Integrated Care of Hemophilia and Hemoglobinopathies
-
Feb 16, 2026, 13:21Quamruz Zafar: Using the FAST Approach Saves Lives and Reduces Long Term Disability
-
Feb 16, 2026, 13:21Christopher Cannon: Factor XIa Inhibition Reduces Stroke by 26% Without Increasing Bleeding
-
Feb 16, 2026, 13:15Rishiraj Sinha: Strengthening Donor Ecosystems to Support Patient Blood Management
-
Feb 16, 2026, 13:13Tarek Dakakni: Mobile Stroke Units Make Treatment Faster, Clearer, and Smarter
-
Feb 16, 2026, 13:03Lamees Alsalehi: Presenting Age, Gender, and Comorbidity Patterns in Stroke at DINC 2026
-
Feb 16, 2026, 12:55Hussein Balfaqih: From Near‑Fatal Hemorrhage to Walking The Ward
-
Feb 16, 2026, 06:21C. Michael Gibson: Favorable Safety Outcomes With Asundexian